HomeNewsWorld NewsFTC Pauses Challenge to Amgen’s $27.8 Billion Deal for Horizon Therapeutics

FTC Pauses Challenge to Amgen’s $27.8 Billion Deal for Horizon Therapeutics

The move gives the agency time to weigh a settlement that would allow the deal to close with conditions.

Leave a Reply

Your email address will not be published. Required fields are marked *

Disclaimer:

Copyright: © 2023 iSeekFX. All Rights Reserved.